Companies / Pyxis Oncology, Inc. / Activity
Activity — Pyxis Oncology, Inc.
13 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 21, 2025 | Humphrey Rachel Director | Sell | Common Stock | $14.4K | -14K -14.60% | 81,309 0.10% of shares | low |
| Apr 14, 2025 | Humphrey Rachel Director | Sell | Common Stock | $1.4K | -1K -1.45% | 95,405 0.11% of shares | low |
| Apr 17, 2025 | Humphrey Rachel Director | Sell | Common Stock | $194 | -200 -0.21% | 95,205 0.11% of shares | low |
| Mar 24, 2026 | Wadhane Jitendra Executive | Grant | Common Stock | $0 | +109K +27.13% | 512,882 0.61% of shares | low |
| Mar 24, 2026 | Dupont Jakob Director | Grant | Stock Option (Right to Buy) | — | +46K | 45,867 0.05% of shares | low |
| Mar 24, 2026 | Wadhane Jitendra Executive | Grant | Stock Option (Right to Buy) | — | +263K | 262,635 0.31% of shares | low |
| Mar 24, 2026 | Flavin John L Director | Grant | Stock Option (Right to Buy) | — | +46K | 45,867 0.05% of shares | low |
| Mar 24, 2026 | Metzger Michael A Director | Grant | Stock Option (Right to Buy) | — | +46K | 45,867 0.05% of shares | low |
| Mar 24, 2026 | Lewis-Hall Freda C Director | Grant | Stock Option (Right to Buy) | — | +46K | 45,867 0.05% of shares | low |
| Mar 24, 2026 | Cline Darren S Director | Grant | Stock Option (Right to Buy) | — | +46K | 45,867 0.05% of shares | low |
| Mar 24, 2026 | Humphrey Rachel Director | Grant | Stock Option (Right to Buy) | — | +46K | 45,867 0.05% of shares | low |
| Mar 24, 2026 | Palani Santhosh Director | Grant | Stock Option (Right to Buy) | — | +46K | 45,867 0.05% of shares | low |
| Feb 3, 2026 | Civik Thomas CEO | Grant | Stock Option (Right to Buy) | — | +690K | 690,131 0.83% of shares | low |